The case for & against
Bull & Bear analysis
Bullish
Centene Corporation (NYSE:CNC) is a leading healthcare enterprise focused on providing government-sponsored programs, including Medicaid and Medicare. Centene operates in a well-established market, emphasizing cost-effective and innovative healthcare solutions tailored for low-income and underserved populations. The company’s adaptability to regulatory changes and commitment to improving affordable healthcare delivery equip it to remain a critical player in the evolving healthcare landscape.
Bull says
- ↑Q2 revenue $44.4 B, 13% above estimates; net income $1.09 B.
- ↑Adjusted EPS $2.51 beat; FY26 EPS guidance raised >$4.80.
- ↑HBR improved to 89.6% from 93%; disciplined cost management.
- ↑Securing favorable Medicaid rates via proactive state partnerships.
- ↑Investing in AI to drive efficiency and cost control.
- ↑Strong momentum factors and ~1% dividend yield support valuation.
Bear says
- ↓Medicaid membership fell to 12.1 M; forecasted down 8–9% Y/Y.
- ↓Profitability challenges: Q3 near breakeven and potential Q4 loss.
- ↓Rising medical cost trends, especially in behavioral health, pressure margins.
- ↓Weak earnings yield and elevated leverage expose financial stability risk.
- ↓Regulatory rate-setting uncertainties may hinder member retention and pricing.
- ↓Low institutional ownership suggests limited investor confidence in stock.
Investment themes with CNC
Health Care Providers↓ -0.37%
UNH · CVS · HCA
Earnings Call · Q2 2025 · Mgmt. Guidance
Updated 07-29-2026neutral
Transcript signals
Read full transcript analysis ›